Psychodynamic Perspectives on Personality
Precipitation Titration: Endpoint Detection Methods
FDA Approved Drugs: Changes to Approved Drugs
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
The Behavioral Perspective on Personality
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
Vanitha Sekar1, Jeffrey Siegel2
1Division of Biomedical Informatics, Research, and Biomarker Development, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA. vanitha.sekar@fda.gov.
No abstract available in PubMed .